Treatment of chronic total coronary occlusions with drug‐eluting stents

作者： David E. Kandzari

关键词: Internal medicine 、 Restenosis 、 Cardiology 、 Percutaneous coronary intervention 、 Medicine 、 Drug

摘要:

参考文章(29)

Humberto J. Colmenarez, Javier Escaned, Cristina Fernández, Liliana Lobo, Sara Cano, Juan G. del Angel, Fernando Alfonso, Pilar Jimenez, Camino Bañuelos, Nieves Gonzalo, Eulogio García, Rosana Hernández, Carlos Macaya, Efficacy and Safety of Drug-Eluting Stents in Chronic Total Coronary Occlusion Recanalization: A Systematic Review and Meta-Analysis Journal of the American College of Cardiology. ,vol. 55, pp. 1854- 1866 ,(2010) , 10.1016/J.JACC.2009.12.038

David E. Kandzari, Sunil V. Rao, Jeffrey W. Moses, Vladimir Dzavik, Bradley H. Strauss, Michael J. Kutryk, Charles A. Simonton, Jyotsna Garg, Yuliya Lokhnygina, G.B. John Mancini, Eunice Yeoh, Christopher E. Buller, Clinical and Angiographic Outcomes With Sirolimus-Eluting Stents in Total Coronary Occlusions JACC: Cardiovascular Interventions. ,vol. 2, pp. 97- 106 ,(2009) , 10.1016/J.JCIN.2008.10.013

Sunao Nakamura, Tamil S Selvan, Jang-Ho Bae, Yeo H Cahyadi, Orathai Pachirat, 1024-49 Impact of sirolimus-eluting stents on the outcome of patients with chronic total occlusions: Multicenter registry in Asia Journal of the American College of Cardiology. ,vol. 43, ,(2004) , 10.1016/S0735-1097(04)90149-0

Myeong-Ki Hong, Gary S. Mintz, Cheol Whan Lee, Young-Hak Kim, Seung-Whan Lee, Jong-Min Song, Ki-Hoon Han, Duk-Hyun Kang, Jae-Kwan Song, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park, Incidence, Mechanism, Predictors, and Long-Term Prognosis of Late Stent Malapposition After Bare-Metal Stent Implantation Circulation. ,vol. 109, pp. 881- 886 ,(2004) , 10.1161/01.CIR.0000116751.88818.10

Horst Sievert, Stefan Rohde, Andreas Utech, Ralph Schulze, Detlef Scherer, Hartmut Merle, Roland Ensslen, Rainer Schräder, Hans Spies, Andreas Fach, Stent or angioplasty after recanalization of chronic coronary occlusions? (The SARECCO Trial). American Journal of Cardiology. ,vol. 84, pp. 386- 390 ,(1999) , 10.1016/S0002-9149(99)00320-3

Gerald S. Werner, Gero Schwarz, Dirk Prochnau, Michael Fritzenwanger, Andreas Krack, Stefan Betge, Hans R. Figulla, Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: a strategy of extensive lesion coverage with drug-eluting stents. Catheterization and Cardiovascular Interventions. ,vol. 67, pp. 1- 9 ,(2006) , 10.1002/CCD.20437

Sunao Nakamura, Tamil Selvan Muthusamy, Jang-Ho Bae, Yeo Hans Cahyadi, Wasan Udayachalerm, Damras Tresukosol, Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions. American Journal of Cardiology. ,vol. 95, pp. 161- 166 ,(2005) , 10.1016/J.AMJCARD.2004.08.088

Alexandre Abizaid, Charles Chan, Yean-Teng Lim, Upendra Kaul, Nakul Sinha, Tejas Patel, Huay-Cheem Tan, Julio Lopez-Cuellar, Efrain Gaxiola, Saligram Ramesh, Alfredo Rodriguez, Mary E Russell, WISDOM Investigators, Twelve-Month Outcomes With a Paclitaxel-Eluting Stent Transitioning from Controlled Trials to Clinical Practice (the WISDOM Registry) The American Journal of Cardiology. ,vol. 98, pp. 1028- 1032 ,(2006) , 10.1016/J.AMJCARD.2006.05.020

Raúl Moreno, Eulogio Garcia, Rui Teles, Manuel Almeida, Henrique Carvalho, Manel Sabate, Roberto Martin-Reyes, José Rumoroso, Guillermo Galeote, Francisco Goicolea, José Moreu, Vicente Mainar, Josefa Mauri, Rui Ferreira, Mariano Valdes, Armando Perez de Prado, Victoria Martin-Yuste, Santiago Jimenez-Valero, Angel Sanchez-Recalde, Luis Calvo, Esteban Lopez de Sa, Carlos Macaya, Jose-Luis Lopez-Sendon, A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated by EveroLimus-Eluting Stent) trial. Eurointervention. ,vol. 6, pp. 112- 116 ,(2010) , 10.4244/EIJV6I1A17